Colombia INVIMA registration 20209614

RAPID COVID-19 ANTIGEN SELF-TEST

Name: RAPID COVID-19 ANTIGEN SELF-TEST — Colombia INVIMA registration 20209614
Creator: DHM GLOBAL BUSINESS & TRADE S.A.S.
Keywords: RAPID COVID-19 ANTIGEN SELF-TEST, 20209614, III, INVIMA registration

HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANYIIIColombia INVIMA

VerifiedINVIMA · official registry

Device classification

Registered product (Spanish): RAPID COVID-19 ANTIGEN SELF-TEST
Risk class / Clase de riesgo: III
Product group (Spanish): REACTIVO DIAGNOSTICO

Registration information

Sanitary registration: 20209614
Expediente: 20209614
Status / Estado: Negado

Registration holder / Titular

Name: DHM GLOBAL BUSINESS & TRADE S.A.S.

Associated party / Rol

Name: HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY
Role: FABRICANTE
Country: ESTADOS UNIDOS DE AMÉRICA
Manufacturer: HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY

About this record

Access comprehensive regulatory information for RAPID COVID-19 ANTIGEN SELF-TEST in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA sanitary registration 20209614, held by DHM GLOBAL BUSINESS & TRADE S.A.S. and associated with HEALGEN SCIENTIFIC LIMITED LIABILITY COMPANY (FABRICANTE).

This page provides complete registration details including product group (REACTIVO DIAGNOSTICO), holder and associated-party information, and regulatory data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.